De LucaD, van KaamAH, TingayDG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med., 2017; 5(8):657–666.
2.
De LucaD, TingayDG, van KaamAH, et al; Neonatal ARDS Project Collaboration Group. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatr Crit Care Med., 2022; 23(7):524–534.
3.
KneyberMCJ, de LucaD, CalderiniE, et al; section Respiratory Failure of the European Society for Paediatric and Neonatal Intensive Care. Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC). Intensive Care Med., 2017; 43(12):1764–1780.
4.
DelilogluB, TuzunF, CengizMM, OzkanH, DumanN. Endotracheal surfactant combined with budesonide for neonatal ARDS. Front Pediatr., 2020; 8:210.
5.
De LucaD, Lopez-RodriguezE, MinucciA, et al. Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants. Crit Care., 2013; 17(4):R163.
6.
De LucaD, BaroniS, VentoG, et al. Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med., 2008; 34(10):1858–1864.
7.
De LucaD, MinucciA, TripodiD, et al. Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Med., 2011; 37(7):1158–1165.
8.
RileyDS, BarberMS, KienleGS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol., 2017; 89:218–235.
9.
SongsangvornN, XuY, LuC, et al. Electrical impedance tomography-guided positive end-expiratory pressure titration in ARDS: a systematic review and meta-analysis. Intensive Care Med., 2024; 50(5):617–631.
10.
FranchineauG, BréchotN, LebretonG, et al. Bedside contribution of electrical impedance tomography to setting positive end-expiratory pressure for extracorporeal membrane oxygenation-treated patients with severe acute respiratory distress syndrome. Am J Respir Crit Care Med., 2017; 196(4):447–457.
11.
LoiB, SartoriusV, VivaldaL, et al. Global and regional heterogeneity of lung aeration in neonates with different respiratory disorders: a physiological, observational study. Anesthesiology., 2024; 141(4):719–731.
12.
ChenD-M, WuL-Q, WangR-Q. Efficiency of high-frequency oscillatory ventilation combined with pulmonary surfactant in the treatment of neonatal meconium aspiration syndrome. Int J Clin Exp Med., 2015; 8(8):14490–14496.
13.
BoetA, BratR, AguileraSS, TissieresP, De LucaD. Surfactant from neonatal to pediatric ICU: bench and bedside evidence. Minerva Anestesiol., 2014; 80(12):1345–1356.
14.
TriggianiM, GranataF, PetraroliA, et al. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide. Int Arch Allergy Immunol., 2009; 150(2):144–155.
15.
WatsonRS, BeersSR, AsaroLA, et al; RESTORE-Cognition Investigators. Association of acute respiratory failure in early childhood with long-term neurocognitive outcomes. JAMA., 2022; 327(9):836–845.
